News
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Spectrum Pharmaceuticals (NASDAQ: SPPI), a biotech developing treatments for various blood disorders and cancers, saw its shares gain as much as 51.7% today on over 19 times the average volume.....
Why SUPERVALU, Synchronoss Technologies, and Allergan Slumped Today
Wednesday was generally a good day for the stock market, with major benchmarks posting solid gains. Broad measures like the S&P 500 and the Nasdaq Composite were up just modestly from....
Here's Why Ignyta Stock Soared as Much as 27.5% Today
Shares of pre-revenue biopharma Ignyta (NASDAQ: RXDX) jumped over 27% Wednesday morning after it announced promising interim results from an ongoing phase 2/3 clinical trial investigating the....
Why Endocyte Is Rallying Today
Shares of Endocyte (NASDAQ: ECYT), a clinical-stage biotech focused on cancer, rose as much as 13% in early-morning trading on Tuesday on heavy volume. As of 11:35 p.m. EDT, the stock was up about....
10 Stunning Numbers You Need to Know About Breast Cancer
October is breast cancer awareness month. Of course, for many American families, there's no need for a month to be designated to remember breast cancer. They're more than aware of the disease....
The Most Disappointing Marijuana Stock Plunged Once Again Last Week
The legal-marijuana industry is growing at an incredible pace, which is a big reason why investors seemingly can't get enough of pot stocks. According to Marijuana Business Daily's latest report,....
What's Powering Johnson & Johnson's Impressive Quarterly Earnings?
Johnson & Johnson (NYSE: JNJ) surprised investors with better-than-hoped-for top-line and bottom-line performance in the third quarter, and that news sent shares soaring on Tuesday. The....
3 Things You Won't Learn by Focusing on Johnson & Johnson's Headline Figures in Its Q3 Report
Johnson & Johnson (NYSE: JNJ) often kicks things off for the healthcare sector with the release of its quarterly earnings, and once again, the largest healthcare company by market cap....
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) are both clinical-stage biotechs that could make you rich, but they'll need to carry at least one of their new....
Here's Why AVEO Pharmaceuticals Dropped as Much as 16.3% Today
Shares of surprise biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) dropped over 16% today on nearly twice the daily average trading volume without any major news story breaking. What's going on?....
Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)
Johnson & Johnson (NYSE: JNJ)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOctober 17, 2017, 8:30 a.m. ETContinue readingSource: Fool.com
Johnson & Johnson Jumps on Pharma Strength
Johnson & Johnson (NYSE: JNJ) has been a behemoth in the U.S. healthcare space for decades. Yet as a mature company, J&J faces the inevitable challenge of finding ways to keep its growth....
Why Impax Laboratories Inc Is Tanking Today
After confirming that it will be merging with a privately held drug manufacturer, shares of Impax Laboratories (NASDAQ: IPXL), a maker of generic and branded drugs, fell 10% as of 12:00 p.m. EDT....
Why TransEnterix Stock Is Soaring Today
Shares of the robotic-surgery company TransEnterix (NYSEMKT: TRXC) rose by as much as 69% today in early morning trading. This small-cap healthcare stock has now appreciated by over 200% since the....
3 Dividend Healthcare Stocks
Healthcare stocks have been extremely fertile ground for dividend investors over the last few years -- thanks, in large part, to the aging global population that's presently driving a surge in....
Why Exelixis' Rebound Is Just Getting Started
Exelixis (NASDAQ: EXEL) stock had been in the doldrums. After roaring for much of the first eight months of the year, the biotech's share price sank more than 15% during September. All of that is....
3 Drug Stocks Hitting 52-Week Highs: Are They Buys?
October has often been a scary month for stocks. That isn't the case so far this year, though. And it's especially not true for three drug stocks.Biogen (NASDAQ: BIIB), Halozyme Therapeutics....
Where Will Opko Health Inc. Be in 5 Years?
Opko Health (NASDAQ: OPK) has had a rough year no matter how you look at it. So far in 2017, shares of the pharmaceutical and diagnostics company are down more than 20%. At one point, Opko stock....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Press Release
Paris & New York, 16 October 2017
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Quantum Genomics....
Quantum Genomics nominée pour le prix Galien MedStartUp pour le design innovant de son étude NEW-HOPE
Communiqué de presse
Paris, le 16 octobre 2017
Quantum Genomics (Euronext Growth - FR0011648971 – ALQGC), société biopharmaceutique spécialisée dans le développement d'une nouvelle classe de....
Why Exelixis, Inc. Rose Higher Today
Exelixis (NASDAQ: EXEL) is up 24% at 12:21 p.m. EDT after announcing that the phase 3 Celestial trial met its primary endpoint of helping liver cancer patients taking Cabometyx live longer than....
3 Marijuana Stocks That Like to Live Life Dangerously
In case you haven't noticed, marijuana stocks are absolutely on fire. Many of the largest pot stocks by market cap have seen their valuations double, triple, or perhaps head even higher over the....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....